Gillian C Ivers-read - Net Worth and Insider Trading
Gillian C Ivers-read Net Worth
The estimated net worth of Gillian C Ivers-read is at least $4,404 dollars as of 2024-12-01. Gillian C Ivers-read is the See Remarks of Clovis Oncology Inc and owns about 293,612 shares of Clovis Oncology Inc (CLVSQ) stock worth over $4,404. Details can be seen in Gillian C Ivers-read's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gillian C Ivers-read has not made any transactions after 2022-11-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gillian C Ivers-read
Gillian C Ivers-read Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gillian C Ivers-read owns 2 companies in total, including Clovis Oncology Inc (CLVSQ) , and Bio-Path Holdings Inc (BPTH) .
Click here to see the complete history of Gillian C Ivers-read’s form 4 insider trades.
Insider Ownership Summary of Gillian C Ivers-read
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CLVSQ | Clovis Oncology Inc | 2022-11-02 | See Remarks |
BPTH | Bio-Path Holdings Inc | 2008-09-10 | director |
Gillian C Ivers-read Latest Holdings Summary
Gillian C Ivers-read currently owns a total of 1 stock. Gillian C Ivers-read owns 293,612 shares of Clovis Oncology Inc (CLVSQ) as of November 2, 2022, with a value of $4,404.
Latest Holdings of Gillian C Ivers-read
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CLVSQ | Clovis Oncology Inc | 2022-11-02 | 293,612 | 0.02 | 4,404 |
Holding Weightings of Gillian C Ivers-read
Gillian C Ivers-read Form 4 Trading Tracker
According to the SEC Form 4 filings, Gillian C Ivers-read has made a total of 26 transactions in Clovis Oncology Inc (CLVSQ) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in Clovis Oncology Inc is the sale of 3,681 shares on November 2, 2022, which brought Gillian C Ivers-read around $3,607.
Insider Trading History of Gillian C Ivers-read
- 1
Gillian C Ivers-read Trading Performance
GuruFocus tracks the stock performance after each of Gillian C Ivers-read's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gillian C Ivers-read is 88.92%. GuruFocus also compares Gillian C Ivers-read's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gillian C Ivers-read within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gillian C Ivers-read's insider trading performs compared to the benchmark.
Performance of Gillian C Ivers-read
Gillian C Ivers-read Ownership Network
Gillian C Ivers-read Owned Company Details
What does Clovis Oncology Inc do?
Who are the key executives at Clovis Oncology Inc?
Gillian C Ivers-read is the See Remarks of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Paul Edward Gross , and See remarks Daniel W Muehl .
Clovis Oncology Inc (CLVSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clovis Oncology Inc Insider Transactions
Gillian C Ivers-read Mailing Address
Above is the net worth, insider trading, and ownership report for Gillian C Ivers-read. You might contact Gillian C Ivers-read via mailing address: C/o Pharmion Corporation, 2525 28th Street, Boulder Co 80301.